- Federal agenciesRaises federal tax revenue by disallowing deductions and credits for marijuana businesses.
- Federal agenciesAligns federal tax policy with federal controlled substances law and its enforcement objectives.
- Federal agenciesPrevents businesses trafficking federally prohibited substances from obtaining tax benefits available to lawful busines…
No Deductions for Marijuana Businesses Act
Referred to the House Committee on Ways and Means.
This bill amends Internal Revenue Code section 280E to explicitly prohibit any deduction or tax credit for trades or businesses that traffic in marijuana (as defined in the Controlled Substances Act) or other Schedule I or II controlled substances. The prohibition applies to amounts paid or incurred after enactment in taxable years ending after that date.
Progressives emphasize economic harm and social equity impacts on cannabis businesses
Technically narrow but touches a contentious issue; may attract both supporters and opponents, producing mixed legislative support.
This bill amends Internal Revenue Code section 280E to explicitly prohibit any deduction or tax credit for trades or businesses that traffic in marijuana (as defined in the Controlled Substances Act) or other Schedule I or II controlled substances.
The prohibition applies to amounts paid or incurred after enactment in taxable years ending after that date.
The change preserves federal tax treatment that denies ordinary business deductions to marijuana-related businesses, even if those businesses operate legally under state law.
Narrow administrative change with political resonance; short text aids enactment, but controversy over cannabis and federal-state tension reduce chances.
How solid the drafting looks.
Progressives emphasize economic harm and social equity impacts on cannabis businesses
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Federal agenciesRaises effective federal tax rates for state-legal marijuana businesses, reducing profitability.
- StatesCould reduce investment and job growth in state-legal marijuana industries by lowering returns.
- Potential burdenIncreases compliance complexity and tax planning costs for cannabis businesses and accountants.
Why the argument around this bill splits.
Progressives emphasize economic harm and social equity impacts on cannabis businesses
Likely opposed.
They will view the bill as an economic penalty on state-legal marijuana businesses, harming workers, small operators, and equity-focused entrants.
They see it as inconsistent with state legalization and medical access priorities.
Mixed/unsure.
They will appreciate statutory clarity and respect for federal law, but worry about unfair tax burdens on state-legal businesses and unintended economic or administrative consequences.
Supportive.
They will view the bill as upholding federal criminal law and preventing federal tax benefits for trafficking in controlled substances, including marijuana.
It aligns with law-and-order and non‑endorsement of federally illegal activity.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow administrative change with political resonance; short text aids enactment, but controversy over cannabis and federal-state tension reduce chances.
- No CBO revenue or distribution estimate provided
- How rescheduling or federal cannabis reforms would interact
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Progressives emphasize economic harm and social equity impacts on cannabis businesses
Narrow administrative change with political resonance; short text aids enactment, but controversy over cannabis and federal-state tension r…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for No Deductions for Marijuana Businesses Act.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.